$ARMK Income Statement | Understand Stock

$ARMK

$55.21 +$0.82 (1.5%) Live

$ARMK Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Income

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Oct 3, 2025	FY2024 12 months to Sep 27, 2024	FY2023 12 months to Sep 29, 2023	FY2022 12 months to Sep 30, 2022	FY2021 12 months to Oct 1, 2021
Revenue
Costs and Expenses:
Cost of services provided (exclusive of depreciation and amortization)
Depreciation and amortization
Selling and general corporate expenses
Goodwill impairment
Gain on sale of Healthcare Technologies
Total costs and expenses

Operating income
Gain on Equity Investment
Loss (Gain) on equity investments, net (see Note 1)
Loss on Defined Benefit Pension Plan Termination
Interest and Other Financing Costs, net
Interest Expense, net
Income from Continuing Operations Before Income Taxes
Provision for Income Taxes from Continuing Operations
Net income (loss)
Net income from Continuing Operations
Less: Net income (loss) attributable to noncontrolling interests
Net income from Continuing Operations attributable to Aramark stockholders
Income from Discontinued Operations, net of tax
Net income attributable to Aramark stockholders
Basic earnings per share attributable to Aramark stockholders:
Income from continuing operations (in dollars per share)
Income from discontinued operations (in dollars per share)
Basic earnings per share attributable to Aramark stockholders (in dollars per share)
Diluted earnings per share attributable to Aramark stockholders:
Income from continuing operations (in dollars per share)
Income from discontinued operations (in dollars per share)
Diluted earnings per share attributable to Aramark stockholders (in dollars per share)
Weighted Average Shares Outstanding:
Basic (in shares)
Diluted (in shares)

Comments